J Psychiatry Neurosci 2006;31(1)
Editorial
Discontinuing treatment for psychiatric disorders
R.T. Joffe
Commentary
Ecological momentary assessment: what it is and why it is a method of the future in clinical psychopharmacology
D.S. Moskowitz, S.N. Young
Review Paper
Brain imaging and cognitive dysfunctions in Huntington’s disease
A. Montoya, B.H. Price, M. Menear, M. Lepage
Research Papers
Antipsychotic drugs cause glial cell line–derived neurotrophic factor secretion from C6 glioma cells
Z. Shao, L.E. Dyck, H. Wang, X.M. Li
Does naltrexone treatment lead to depression? Findings from a randomized controlled trial in subjects with opioid dependence
A.J. Dean, J.B. Saunders, R.T. Jones, R.M. Young, J.P. Connor, B.R. Lawford
Efficacy of methylphenidate in children with attention-deficit hyperactivity disorder and learning disabilities: a randomized crossover trial
N. Grizenko, M. Bhat, G. Schwartz, M. Ter-Stepanian, R. Joober
Psychopharmacology for the Clinician
Managing discontinuation syndrome in patients with dementia
S. Gauthier